Company / Cash per Share
Inhibikase Therapeutics, Inc. Cash per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$9.13
FY2024
5-year range
$0.29 / $9.13
FY2022-FY2024
Trend
+320.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +321% YoY in FY2024, a notable deviation from the 2-year average annual change of +490%.
Based on SEC 10-K filings.
9.13 in FY2024.
Improved from $0.29 to $9.13 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, cash per share increased 320.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $9.13 | +320.7% |
| FY2023 | $2.17 | +659.5% |
| FY2022 | $0.29 | - |
| FY2021 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026